Previous 10 |
NEW YORK, NY / ACCESSWIRE / April 29, 2019 / Bexil Corporation (OTC PINK: BXLC ) today reported its financial results for the year ended December 31, 2018. Bexil recorded a net loss attributable to Bexil shareholders of $1.27 million or $1.43 per diluted share for the year ended December 31...
NEW YORK, NY / ACCESSWIRE / October 30, 2018 / Bexil Corporation (OTC PINK: BXLC) ("Bexil" or the "Company") today reported its financial results for the third quarter ended September 30, 2018. For the three months ended September 30, 2018, Bexil recorded a net loss attributable to Bexil s...
NEW YORK, NY / ACCESSWIRE / August 14, 2018 / Bexil Corporation (OTC PINK: BXLC) (''Bexil'' or the ''Company'') today reported its financial results for the second quarter ended June 30, 2018. For the three months ended June 30, 2018, Bexil recorded net income attributable to Bexil sharehol...
NEW YORK, NY / ACCESSWIRE / August 10, 2018 / Bexil Corporation (OTC PINK: BXLC ) ("Bexil" or the "Company") is pleased to announce today the results of its tender offer, which expired at 5:00 p.m. ET on August 9, 2018. Based on the final count by Securities Transfer Corporation, the depo...
NEW YORK, NY / ACCESSWIRE / July 3, 2018 / Bexil Corporation (OTC PINK: BXLC ) (''Bexil'' or the ''Company'') today announced that it invites its shareholders to tender for $13.25 per share in cash up to an aggregate of 25,000 shares of the Company's common stock. A shareholder may particip...
NEW YORK, NY / ACCESSWIRE / May 4, 2018 / Bexil Corporation (OTC PINK: BXLC ) today reported its financial results for the first quarter ended March 31, 2018. For the three months ended March 31, 2018, Bexil recorded a net loss attributable to Bexil shareholders of approximately $0.90 mil...
NEW YORK, NY / ACCESSWIRE / May 4, 2018 / Bexil Corporation (OTC PINK: BXLC ) today reported its financial results for the year ended December 31, 2017. Bexil recorded net income attributable to Bexil shareholders of $1.90 million or $2.02 per diluted share for the year ended December 31, 2...
News, Short Squeeze, Breakout and More Instantly...
Biomerieux (BMXMF) is expected to report for Q1 2024 Conn's Inc. (CONN) is expected to report $-0.65 for Q1 2025 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for quarter end 2024-04-30 Aridis Pharmaceuticals Inc. (ARDS) is expected to report for Q1 2024 China Jo-Jo ...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Commercial Metals Company (CMC) is expected to report $1 for Q3 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 GMS Inc. (GMS) is expected to report $2.04 for Q4 2024 China Jo-Jo Drugstores Inc. (CJJD) is expected to report for Q4 2024 Eiger BioPharmaceuticals Inc. (EIGR...